纳米技术
核酸
微流控
材料科学
核酸定量
检出限
脱氧核酶
滚动圆复制
注意事项
DNA
计算生物学
聚合酶
生物
化学
遗传学
医学
护理部
色谱法
作者
Renukka Yaadav,Kateryna Trofymchuk,Mihir Dass,Vivien Behrendt,Benedikt Hauer,Jan Schütz,Cindy Close,Michael Scheckenbach,Giovanni Ferrari,Leoni Mäurer,Sophia Sebina,Viktorija Glembockyte,Tim Liedl,Philip Tinnefeld
标识
DOI:10.1002/adma.202507407
摘要
Abstract Creating increasingly sensitive and cost‐effective nucleic acid detection methods is critical for enhancing point‐of‐care (POC) applications. This requires highly specific capture of biomarkers and efficient transduction of capture events. However, the signal from biomarkers present at extremely low amounts often falls below the detection limit of typical fluorescence‐based methods, necessitating molecular amplification. Here, we present single‐molecule detection of a non‐amplified, 151‐nucleotide sequence specific to antibiotics‐resistant Klebsiella pneumoniae down to attomolar concentrations, using Trident NanoAntennas with Cleared HOtSpots (NACHOS). This NACHOS‐diagnostics assay leverages a compact microscope with a large field‐of‐view, including microfluidic flow to enhance capturing efficiency. Fluorescence enhancement is provided by NanoAntennas, arranged using a combination of nanosphere lithography and site‐specific DNA origami placement. This method can detect 200 ± 50 out of 600 molecules in a 100 µL sample volume within an hour. This represents a typical number of pathogens in clinical samples commonly detected by Polymerase Chain Reaction. We achieve similar sensitivity in untreated human plasma, enhancing the practical applicability of the system. This platform can be adapted to detect shorter nucleic acid fragments that are not compatible with traditional amplification‐based technologies. This provides a robust and scalable solution for sensitive nucleic acid detection in diverse clinical settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI